Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China flag China · Delayed Price · Currency is CNY
170.00
-0.44 (-0.26%)
At close: Feb 6, 2026

SHA:600436 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
9,74810,75610,0368,6748,0046,493
Other Revenue
31.8731.8722.3119.5217.2918.28
9,78010,78810,0588,6948,0226,511
Revenue Growth (YoY)
-10.35%7.25%15.70%8.38%23.20%13.78%
Cost of Revenue
6,1246,1895,3634,7353,9683,584
Gross Profit
3,6564,5994,6953,9594,0542,926
Selling, General & Admin
845.21858.091,150814.411,027982.2
Research & Development
304.97269.59232.35230.03199.5197.55
Other Operating Expenses
26.9548.1970.7771.9672.0553.23
Operating Expenses
1,1841,1791,4651,1101,3061,135
Operating Income
2,4723,4203,2302,8492,7481,792
Interest Expense
-31.29-37.62-37.31-38.01-32.9-27.39
Interest & Investment Income
424.23182.59170.81171.62144.48149.27
Currency Exchange Gain (Loss)
7.577.573.097.18-3.28-3.27
Other Non Operating Income (Expenses)
-14.33-3.036.02-36.47-21.62-4.4
EBT Excluding Unusual Items
2,8583,5693,3732,9542,8341,906
Gain (Loss) on Sale of Investments
-1.51-8.958.32-0.024.546.72
Gain (Loss) on Sale of Assets
3.993.870.9611.1427.5940.29
Asset Writedown
1---0.33-1.02-
Other Unusual Items
-25.54-25.54-13.0613.183.5526.08
Pretax Income
2,8363,5393,3692,9782,8691,979
Income Tax Expense
424.7543.21517.77454.76404.23289.54
Earnings From Continuing Operations
2,4112,9962,8512,5232,4651,689
Minority Interest in Earnings
8.59-18.52-53.79-50.63-32.9-17.84
Net Income
2,4202,9772,7972,4722,4321,672
Net Income to Common
2,4202,9772,7972,4722,4321,672
Net Income Growth
-21.42%6.42%13.15%1.66%45.49%21.62%
Shares Outstanding (Basic)
603604603603603603
Shares Outstanding (Diluted)
603604603603603603
Shares Change (YoY)
-0.04%0.16%-0.02%-0.07%0.00%0.11%
EPS (Basic)
4.014.934.644.104.032.77
EPS (Diluted)
4.014.934.644.104.032.77
EPS Growth
-21.39%6.25%13.17%1.74%45.49%21.49%
Free Cash Flow
-704.71245.412,0656,698370.111,048
Free Cash Flow Per Share
-1.170.413.4211.110.611.74
Dividend Per Share
1.8202.9702.3201.2501.2100.900
Dividend Growth
-47.55%28.02%85.60%3.31%34.44%9.76%
Gross Margin
37.38%42.63%46.68%45.54%50.53%44.95%
Operating Margin
25.27%31.70%32.11%32.77%34.25%27.52%
Profit Margin
24.74%27.60%27.81%28.44%30.32%25.67%
Free Cash Flow Margin
-7.21%2.27%20.53%77.04%4.61%16.10%
EBITDA
2,5173,4753,2982,8972,8541,882
EBITDA Margin
25.74%32.21%32.79%33.32%35.58%28.90%
D&A For EBITDA
45.395567.8247.36106.2590.21
EBIT
2,4723,4203,2302,8492,7481,792
EBIT Margin
25.27%31.70%32.11%32.77%34.25%27.52%
Effective Tax Rate
14.98%15.35%15.37%15.27%14.09%14.63%
Revenue as Reported
9,78010,78810,0588,6948,0226,511
Advertising Expenses
-258.62531.48255.04445473.79
Source: S&P Global Market Intelligence. Standard template. Financial Sources.